BIOTECHQUITY Trademark
Trademark Overview
On Monday, April 8, 2024, a trademark application was filed for BIOTECHQUITY with the United States Patent and Trademark Office. The USPTO has given the BIOTECHQUITY trademark a serial number of 98489553. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, October 29, 2024. The BIOTECHQUITY trademark is filed in the Advertising, Business and Retail Services category with the following description:
Market research and business marketing consulting services for life sciences companies, organizations, and institutions; Providing business and biostatistical business information and business data analysis services for life sciences companies, organizations, and institutions; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of life sciences companies to assist them with clinical research, clinical trials, and applications for drug approval; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Business consulting and business management services for life sciences companies, organizations, and institutions in the fields of health economics, outcomes research, epidemiological studies, payer research, and market access; Promoting public and government awareness of and interest ...
General Information
Serial Number | 98489553 |
Word Mark | BIOTECHQUITY |
Filing Date | Monday, April 8, 2024 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Tuesday, October 29, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, January 14, 2025 |
Trademark Statements
Pseudo Mark | BIO TECH EQUITY |
Goods and Services | Market research and business marketing consulting services for life sciences companies, organizations, and institutions; Providing business and biostatistical business information and business data analysis services for life sciences companies, organizations, and institutions; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of life sciences companies to assist them with clinical research, clinical trials, and applications for drug approval; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Business consulting and business management services for life sciences companies, organizations, and institutions in the fields of health economics, outcomes research, epidemiological studies, payer research, and market access; Promoting public and government awareness of and interest in issues relating to acceleration of medical solutions; promotion of public policies to accelerate development and adoption of new drugs and therapies; conducting post market research studies |
Classification Information
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 8, 2024 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | NOT AVAILABLE |
Party Type | 10 - Original Applicant |
Legal Entity Type | 01 - Individual |
Address | Washington, DC 20015 |
Trademark Events
Event Date | Event Description |
Monday, April 8, 2024 | NEW APPLICATION ENTERED |
Monday, September 16, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 22, 2024 | ASSIGNED TO EXAMINER |
Wednesday, October 23, 2024 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, October 23, 2024 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, October 23, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, October 23, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, October 23, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, January 8, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |